We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Nestle SA (PK) | USOTC:NSRGY | OTCMarkets | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.58 | -0.63% | 91.24 | 91.20 | 91.28 | 91.69 | 90.61 | 91.05 | 523,782 | 19:14:36 |
From Feb 2023 to Feb 2025
--Nestle SA has started a process to sell its peanut-allergy treatment Palforzia, Bloomberg reports, citing unnamed sources.
--Initial bids are expected next month, but no final decision has been made on the timing of any sale, Bloomberg reports.
--Nestle, which bought the maker of Palforzia in a $2.6 billion deal in 2020 and recently announced a $2.1 billion impairment charge on the medication, declined to comment.
Full story: https://bloom.bg/3y2fmuv
Write to Adria Calatayud at adria.calatayud@dowjones.com
(END) Dow Jones Newswires
March 02, 2023 03:27 ET (08:27 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year Nestle (PK) Chart |
1 Month Nestle (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
